USPTO Examiner PONTON JAMES D - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19248839VASCULAR ACCESS DEVICE AND METHODSJune 2025November 2025Allow520YesNo
19018277NEUTRAL DISPLACEMENT MEDICAL CONNECTORJanuary 2025October 2025Allow920NoNo
19017947Plunger Rod for an Auto-InjectorJanuary 2025June 2025Allow520YesNo
19018045Plunger Rod for an Auto-InjectorJanuary 2025May 2025Allow410YesNo
19018513Auto-Injector MethodsJanuary 2025May 2025Allow410YesNo
19019284Auto-Injector METHODSJanuary 2025June 2025Allow510NoNo
19016728Auto-Injector MethodsJanuary 2025May 2025Allow410YesNo
19015014Plunger Rod for an Auto-InjectorJanuary 2025May 2025Allow510NoNo
19014447Auto-Injector MethodsJanuary 2025June 2025Allow510NoNo
19013356Plunger Rod for an Auto-InjectorJanuary 2025May 2025Allow510NoNo
19010652Auto-InjectorJanuary 2025May 2025Allow410YesNo
19010775Auto-Injector MethodsJanuary 2025May 2025Allow410NoNo
18755897Auto-InjectorJune 2024November 2024Allow410NoNo
18755787Auto-InjectorJune 2024October 2024Allow410YesNo
18755814Auto-InjectorJune 2024November 2024Allow520YesNo
18754728Auto-InjectorJune 2024November 2024Allow510YesNo
18755161Auto-InjectorJune 2024December 2024Allow520NoNo
18649581ASPIRATION CATHETER WITH A TIP HAVING ENGAGEMENT EXTENSIONS AND METHODS OF USEApril 2024August 2025Abandon1630YesNo
18621887Refreshing Stylets, Catheter Systems, and Methods ThereofMarch 2024March 2025Allow1210NoNo
18611253Auto-InjectorMarch 2024August 2024Allow510YesNo
18611051Auto-InjectorMarch 2024May 2024Allow200NoNo
18611151Auto-InjectorMarch 2024August 2024Allow410NoNo
18610192LIQUID MEDICINE INJECTION DEVICEMarch 2024April 2025Allow1210YesNo
18596386AUTOMATIC CONFIGURATION OF USER-SPECIFIC DATA BASED ON NETWORKED CHARGER DEVICESMarch 2024September 2025Allow1811YesNo
18413900Auto-InjectorJanuary 2024April 2024Allow300NoNo
18410003DRUG DELIVERY DEVICE WITH PROXIMITY SENSORJanuary 2024August 2025Allow1921NoNo
18543932AUTONOMOUS DRUG DELIVERY SYSTEMDecember 2023May 2025Allow1600NoNo
18537391INJECTION AND INFUSION SITE TREATMENT DEVICES AND METHODSDecember 2023March 2024Allow310YesNo
18511668DEVICE FOR INTRAOCULAR INJECTIONNovember 2023May 2025Allow1820YesNo
18506136PATCH PUMP DEVICE FOR DRUG DELIVERYNovember 2023February 2026Allow2710NoNo
18379603METHODS AND APPARATUS FOR CATHETERS, ADAPTABLE TIPS FOR CATHETERS, INCLUDING FOR ASPIRATION CATHETERS, AND ASPIRATION CATHETERS WITH ADJUSTABLE TIPSOctober 2023February 2024Allow410YesNo
18482051PUMP FOR IMPLANTABLE MEDICAL DEVICESOctober 2023December 2024Allow1410NoNo
18481012Needle Assisted Injection Device Having Reduced Trigger ForceOctober 2023January 2025Allow1610YesNo
18282245DRUG DELIVERY DEVICESeptember 2023June 2024Allow920YesNo
18282248DRUG DELIVERY DEVICESeptember 2023March 2024Allow610YesNo
18243977DAILY TESTOSTERONE DOSING USING WEARABLE DEVICESeptember 2023May 2024Abandon810NoNo
18456137ELECTROPORATION DEVICE WITH DETACHABLE NEEDLE ARRAY WITH LOCK-OUT SYSTEMAugust 2023January 2026Allow2930NoNo
18452743NEEDLE ASSISTED JET INJECTION ADMINISTRATION OF TESTOSTERONE COMPOSITIONSAugust 2023February 2025Abandon1810NoNo
18451968Method of Treatment of a Pulmonary EmbolismAugust 2023May 2025Allow2120YesNo
18221101System For Verifying Connection Points Of An Infusion Set For Patient Medication And Fluid DeliveryJuly 2023September 2024Allow1510NoNo
18330827Medical PumpJune 2023December 2024Allow1810NoNo
18329436SYRINGE DOSE AND POSITION MEASURING APPARATUSJune 2023April 2025Allow2210YesNo
18204882SELF-ACTUATING ARTICLESJune 2023March 2025Allow2120NoNo
18317731SYRINGE EXTRUSION ACCESSORYMay 2023January 2025Abandon2010NoNo
18196271SPLIT AND SIDE-PORTED CATHETER DEVICESMay 2023September 2024Allow1610YesNo
18309138PUMP FOR IMPLANTABLE MEDICAL DEVICESApril 2023August 2023Allow310YesNo
18305883Moving Basal Engine For A Fluid Delivery DeviceApril 2023June 2025Allow2630NoNo
18296162Fluid Delivery Device Having an Insertable Prefilled CartridgeApril 2023August 2024Allow1610NoNo
18116616LIQUID MEDICINE INJECTION DEVICEMarch 2023January 2024Allow1110YesNo
18111383DEVICE FOR SUBCUTANEOUS DELIVERY OF FLUID MEDICAMENTFebruary 2023June 2023Allow410NoNo
18095075Sheath Remover and Methods for Assembly ThereofJanuary 2023June 2023Allow510YesNo
18094672FLUID INJECTOR WITH SYRINGE ENGAGEMENT MECHANISMJanuary 2023October 2025Abandon3310NoNo
18148574SELF-RIGHTING SYSTEMS, METHODS, AND RELATED COMPONENTSDecember 2022November 2024Allow2310YesNo
18069582Drug Delivery Device with Messaging LabelDecember 2022November 2025Allow3440YesNo
18068255PATCH PUMP DEVICE FOR DRUG DELIVERYDecember 2022August 2023Allow820YesNo
18077569SYSTEM AND METHOD FOR ULTRASONIC BLADDER THERAPEUTIC AGENT DELIVERYDecember 2022November 2025Allow3541YesNo
17992831PORTED IV CATHETER HAVING EXTERNAL NEEDLE SHIELD AND INTERNAL BLOOD CONTROL SEPTUMNovember 2022February 2025Allow2720NoNo
17982723CLOSED SYSTEM ELASTOMERIC PUMPING MECHANISMNovember 2022November 2025Allow3630NoNo
17982310CONFIRMATION OF CATHETER PLACEMENT WITHIN A VEINNovember 2022June 2025Allow3130NoNo
17968128BI-LATERAL CATHETER SYSTEM AND METHODS FOR USEOctober 2022January 2025Allow2710YesNo
17954282SYSTEM AND METHOD FOR PREVENTING CROSS-CONTAMINATION IN FLOW GENERATION SYSTEMSSeptember 2022October 2024Allow2510YesNo
17935321Sealing Systems For A Reservoir Of An On-Body InjectorSeptember 2022November 2025Allow3710NoNo
17933856DOSE CONTROL SYSTEM FOR INJECTABLE-DRUG DELIVERY DEVICES AND ASSOCIATED METHODS OF USESeptember 2022October 2024Allow2520YesNo
17949783MODULAR VENTILATION SYSTEMSeptember 2022September 2025Allow3610YesNo
17910010CYLINDER PUMPSeptember 2022January 2026Allow4110NoNo
17888925Method For Attaching A Medical Fluid Injection Device with AdhesiveAugust 2022August 2024Allow2410YesNo
17819171Needle Assisted Injection Device Having Reduced Trigger ForceAugust 2022October 2024Allow2720YesNo
17795863VALVE SHAFT PUMP WITH COORDINATED PUMPING AND VALVING OPERATIONSJuly 2022October 2025Allow3810YesNo
17795811PUMP WITH PUMPING CHAMBER CREATED BY TELESCOPING ACTION DRIVEN BY FRICTIONJuly 2022December 2025Allow4020YesNo
17864153MULTI-MODAL WOUND TREATMENT APPARATUSJuly 2022October 2025Allow3910YesNo
17844635PRECISION LOW-DOSE,LOW-WASTE SYRINGES AND ERGONOMIC ATTACHMENTS THEREFORJune 2022March 2026Allow4540NoNo
17843133Port Interface for Drug Delivery DeviceJune 2022April 2024Allow2220YesNo
17784328INJECTION AND INFUSION SITE TREATMENT DEVICES AND METHODSJune 2022October 2025Allow4110NoNo
17783833MULTI-USE DRUG-DELIVERY DEVICEJune 2022December 2025Allow4210NoNo
17783944TRANSFUSION PUMP WITH AN INSERTION DEVICEJune 2022March 2026Abandon4510NoNo
17805942TAP BLOCK INJECTION DEVICEJune 2022February 2026Allow4510NoNo
17804564SPRAYING ASSEMBLYMay 2022August 2025Allow3910YesNo
17826737MEDICINE INJECTING TIP, HAND PIECE, AND SKIN TREATING DEVICEMay 2022May 2024Allow2420YesNo
17780343DEVICE FOR INJECTING A PRODUCTMay 2022September 2025Allow4010YesNo
17749463COMPACT POSITIVE DISPLACEMENT PUMP FOR WEARABLE DRUG DELIVERY DEVICEMay 2022December 2025Allow4311NoNo
17663993MEDICAL FLUID TRANSFER DEVICEMay 2022June 2025Allow3710YesNo
17662498AGENT DELIVERY DEVICES AND METHODS OF USING THE SAMEMay 2022January 2026Allow4411YesNo
17738217Sheath Remover and Methods for Assembly ThereofMay 2022April 2025Allow3510YesNo
17735616DRUG DELIVERY DEVICEMay 2022April 2025Allow3570NoNo
17727137NEEDLE AND HOUSINGApril 2022January 2026Allow4511YesNo
17770540CatheterApril 2022October 2025Abandon4201NoNo
17656356CLOUD-CONNECTED AMBULATORY PUMP INTEGRATIONMarch 2022July 2022Allow400YesNo
17295277METHODS AND DEVICES FOR TREATING A DISEASE WITH BIOTHERAPEUTICSMarch 2022January 2026Allow5640NoNo
17642345LIGHT-ACTIVATED ULTRASONIC DELIVERY AND MANIPULATION OF LIQUID MEDICATION FROM A DRUG RESERVOIRMarch 2022January 2023Allow1020YesNo
17692123SELECTIVE TISSUE REMOVAL TREATMENT DEVICEMarch 2022July 2025Allow4120YesNo
17688971MEDICAMENT DELIVERY DEVICEMarch 2022May 2025Allow3820NoNo
17653107MODULAR BLOOD GLUCOSE CONTROL SYSTEMSMarch 2022October 2022Allow810YesNo
17674415MEDICAMENT DELIVERY SYSTEM, AND ASSOCIATED METHODFebruary 2022September 2025Allow4310NoNo
17581315DRUG DELIVERY DEVICEJanuary 2022September 2024Allow3120YesNo
17581028AUTONOMOUS DRUG DELIVERY SYSTEMJanuary 2022September 2023Allow2010YesNo
17577071Container for Storing a Drug such as InsulinJanuary 2022June 2024Allow2930YesNo
17576536ELASTIC PHYSIOLOGICAL PATCHJanuary 2022November 2023Allow2210YesNo
17572478IMPLANTABLE ENCAPSULATION DEVICESJanuary 2022December 2023Allow2320YesNo
17564543MICROFABRICATED CATHETER HAVING AN INTERMEDIATE PREFERRED BENDING SECTIONDecember 2021March 2024Allow2710YesNo
17619898DRUG DELIVERY DEVICE WITH PLUNGER ROD HAVING NONUNIFORM STOPPER INTERFACEDecember 2021June 2025Allow4210YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PONTON, JAMES D.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
3
Examiner Affirmed
2
(66.7%)
Examiner Reversed
1
(33.3%)
Reversal Percentile
55.5%
Higher than average

What This Means

With a 33.3% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
12
Allowed After Appeal Filing
3
(25.0%)
Not Allowed After Appeal Filing
9
(75.0%)
Filing Benefit Percentile
36.5%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 25.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner PONTON, JAMES D - Prosecution Strategy Guide

Executive Summary

Examiner PONTON, JAMES D works in Art Unit 3783 and has examined 335 patent applications in our dataset. With an allowance rate of 84.5%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 34 months.

Allowance Patterns

Examiner PONTON, JAMES D's allowance rate of 84.5% places them in the 60% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by PONTON, JAMES D receive 2.45 office actions before reaching final disposition. This places the examiner in the 71% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by PONTON, JAMES D is 34 months. This places the examiner in the 45% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +36.3% benefit to allowance rate for applications examined by PONTON, JAMES D. This interview benefit is in the 84% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 25.1% of applications are subsequently allowed. This success rate is in the 39% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 38.7% of cases where such amendments are filed. This entry rate is in the 59% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 77% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 76.9% of appeals filed. This is in the 68% percentile among all examiners. Of these withdrawals, 40.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 32.0% are granted (fully or in part). This grant rate is in the 19% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 47% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.